Skip to main content
. 2022 Jun 22;149(5):1785–1810. doi: 10.1007/s00432-022-04054-6

Table 1.

Inclusion and exclusion criteria

PICO Inclusion criteria Exclusion criteria
Patients

Cancer patients (all entities and stages)

Adult patients (age > 18)

Guideline-based cancer treatment

Preclinical studies

Study population with children or only precancerous conditions, if numeral details are not reported separately

Primary prevention

Intervention

Every intervention containing homeopathy

No restrictions regarding the type of homeopathy, dose, mode of application

Comparison All possible control groups (active control, placebo, standard care, observation)
Outcome

Influence on toxicity of cancer treatment (skin reaction, nausea and vomiting, joint pain and stiffness, oral mucositis)

Time to drain removal

Survival

Menopausal symptoms

Quality of life and other psychological outcomes

Sleep

Safety and side effects

No patient centred outcomes (e.g. laboratory parameters)
Others

All study types (including SRs, RCTs, CTs, one-armed studies and retrospective studies)

Language: German and English

Full publication

Other publication type than primary investigation/report

Case reports

Gray literature (conference articles, abstracts, comments, letters, ongoing

studies, unpublished literature, etc.)

Full text not available in German or English